About Via Surgical
Via Surgical Ltd. provides lockable fixation solutions for soft tissue repairs. Realizing that soft tissue tends to move, shift, contract and expand, Via Surgical’s products are designed to lock into the tissue, providing a secure fixation. The company was founded in 2012 by a dedicated team with a successful track record in the hernia space. It has raised more than $12 million in funding, led by OTV VC and with an investment from Asian manufacturing giant Catcher Technology, its first in the medical device field. To date, Via Surgical has three FDA clearances, and 17 issued patents in the US and worldwide, and 17 additional provisional patents filed in the US. Via Surgical’s soft tissue fixation system was voted as one of the Top 10 Surgical Solutions by MedTech Outlook Review. The company also received the Seal of Excellence from Horizon 2020, the EU’s research and innovation funding program.
Leadership
